Blood pressure management with an artificial intelligence-enhanced app and wearable devices: My Intelligent Cardiac Assistant (MICArdiac) Randomised Controlled Trial

30 August 2026 (18:00 - 18:15)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Liliana Laranjo

University of Sydney, Sydney (Australia)

3 More presentations in this session

Presentation thumbnail

Efficacy and safety of sacubitril/allisartan plus amlodipine in hypertensive patients not adequately controlled by amlodipine or sacubitril/allisartan monotherapy: the SALUS study

Professor J. Li (Beijing, CN)

Presentation thumbnail

The ELFIE-HYPERTENSION Trial: An international randomized multicenter trial of an artificial intelligence enhanced and gamified mobile health intervention for hypertension management

Doctor K. Santo (Sao Paulo, BR)

Presentation thumbnail

Chemical adherence testing-guided intervention is cost-effective in management of non-adherence to antihypertensive treatment - life-time evaluation of OUTREACH Study

Doctor S. Hames-Fathi (Manchester, GB)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: hypertension

The Event

Event poster

ESC Congress 2026

30 August 2026 18:00 CET

You may be interested in

Webinar

Innovation in the cloud: see what artificial intelligence can do for ICMs

20 July 2022

Congress Presentation

Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study.

5 April 2025

Congress Presentation

Using co-design to develop INTERCEPT, a mobile health (mHealth) App, for the secondary prevention of cardiovascular disease.

23 June 2023

Congress Session

Precision hypertension care: wearables, artificial intelligence agents, and beyond

30 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources